Site menu:

Studies:

COX 2 inhibition

GAGs Synthesis

Hyaluronic Synthesis

Few other studies

IridoForce™ inhibits 31% of the Cyclo Oxygenase II !

Cyclo-oxygenase (COX-2) is an enzyme which is linked to the inflammatory process.
The purpose of the study was to investigate the effects of Iridoforce™ on the in vitro human COX2 assay. COX2 enzyme synthesizes prostaglandins, creating inflammation. In whole anti-inflammatory products pre-vent the prostaglandins from ever being synthesized, reducing or eliminating the pain.

IridoForce™ inhibits up to 31 % of COX-2 activity, and so helps to strongly reduce the inflammation of the joints, without any other medicines with side effects.

Conclusion : Iridoforce™ shows a significant effect in inhibition on human COX2 of 31 %.
This efficiency permits to use Iridoforce™ as a Non-steroidal anti-inflammatory drugs (NSAIDs), which alleviates pain by counter-acting the cyclo-oxygenase (COX) enzyme.).